Presentation The Structural Heart Disease Summit 2018 Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky June 21, 2018
Video » SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future! June 26, 2018
Video » SHDS 2018: Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-Making? June 26, 2018
Video » SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions July 4, 2018
Video » SHDS 2018: Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A) July 4, 2018
Video » SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain! June 26, 2018
Video » SHDS 2018: An Introduction to “VARC-3: A Focused Update” – New Endpoints and Definitions for Aortic Valve Clinical Research June 26, 2018